当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2017年第22期
编号:13084091
舒筋健腰丸对坐骨神经痛大鼠坐骨神经组织及血清细胞因子的影响(4)
http://www.100md.com 2017年10月8日 《中国医药导报》 2017年第22期
     [14] Challa SR. Surgical animal models of neuropathic pain:pros and cons [J]. Int J Neurosci,2015,125(3):170-174.

    [15] Li Q,Tian Y,Wang ZF,et al. Involvement of the spinal NALP1 inflammasome in neuropathic pain and aspirin-triggered-15-epi-lipoxin A4 induced analgesia [J]. Neuroscience,2013,254:230-240.

    [16] Sacerdote P,Franchi S,Moretti S,et al. Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain [J]. J Neuroimmune Pharmacol,2013,8(1):202-211.

    [17] Gong X,Chen Y,Fu B,et al. Infant nerve injury induces delayed microglial polarization to the M1 phenotype,and exercise reduces delayed neuropathic pain by modulating microglial activity [J]. Neuroscience,2017,349:76-86.

    [18] Li K,Tan YH,Light AR,et al. Different peripheral tissue injury induces differential phenotypic changes of spinal activated microglia [J]. Clin Dev Immunol,2013,2013(10):901420.

    [19] Choi HS,Roh DH,Yoon SY,et al. Microglial interleukin-1β in the ipsilateral dorsal horn inhibits the development of mirror-image contralateral mechanical allodynia through astrocyte activation in a rat model of inflammatory pain [J]. Pain,2015,156(6):1046-1059.

    [20] Murakami T,Kanchiku T,Suzuki H,et al. Anti-interleukin-6 receptor antibody reduces neuropathic pain following spinal cord injury in mice [J]. Exp Ther Med,2013,6(5):1194-1198.

    (收稿日期:2017-04-28 本文編辑:李岳泽), 百拇医药(石洪超 欧慧瑜 何风雷)
上一页1 2 3 4